Home / About Us / News

News

Orthopaedic Synergy, Inc. Announces Completion of PRAXIM, SA Acquisition

Monday, 14 June 2010 15:15

EAST TAUNTON, Mass., June 10 -- Orthopaedic Synergy, Inc., is pleased to announce that our acquisition of PRAXIM, SA, Grenoble, France was successfully completed on May 18, 2010.

 

OMNIlife science, Inc., Announces U.S. Distribution Agreement with SERF-Dedienne Sante of France for its 'ION free' Large Diameter Head Dual Mobility Acetabular Cup System

Tuesday, 16 March 2010 18:40

EAST TAUNTON, Mass., March 10 /PRNewswire/ -- OMNIlife science, Inc., is very pleased to announce that it has entered into an exclusive U.S. distribution agreement with Societe d'Etudes Recherches Fabrication (SERF)-Dedienne Sante of France for its NOVAE® Dual Mobility Acetabular Cup System.  OMNI intends to begin distribution of this product in the USA as soon as U.S. FDA approval of the product is achieved.

 

Orthopaedic Synergy, Inc. Announces Letter of Intent to Acquire Praxim, SA.

Tuesday, 16 March 2010 18:29

EAST TAUNTON, Mass., March 9 /PRNewswire/ -- Orthopaedic Synergy, Inc., is pleased to announce that it has entered into a letter of intent and period of exclusivity to acquire Praxim, SA of France.  

 

Amedica® Signs Joint Venture Agreement with Orthopaedic Synergy®

Tuesday, 23 February 2010 17:13

Salt Lake City, February 23, 2010– Amedica Corporation (AC), a spinal and orthopaedic implant and instrument company focused on unique silicon nitride (SiN) ceramic technologies, announced today an agreement with Orthopaedic Synergy, Inc. (OSI) a holding company for OMNIlife Science™ and Enztec, both global designers, manufacturers and distributors of leading edge reconstructive surgery implants and instrumentation.

 

OMNIlife Science receives 510K approval for ApeX-LNK highly Cross Linked polyethylene

Tuesday, 03 March 2009 02:07

OMNI life science, Inc., a medical device company based in Raynham Massachusetts and focused on the design, manufacture and distribution of Orthopaedic Joint Replacement Products, announced today that it had received FDA 510k approval for its proprietary (patent pending) highly cross linked polyethylene.
 
<< Start < Prev 1 2 Next > End >>

Page 1 of 2